Joint Purification Systems
JPS is a clinical stage company developing antibiotics for intra-articular irrigagion to treat peri-prosthetic infection locally, where the infection persists.
Broad spectrum antibiotics are combined with a patented temporary spacer to distribute antibiotics, flushing the joint space hourly. Delivering higher doses of antibiotics directly to the infected site, JPS reduces time to re-implantation from 18 weeks (current practice) to just 7 days.
JPS is recruiting sites for a Phase 3 clinical trail to begin enollment mid-2020.